Showing results (161-170 of 405) with videos related to

Sort By:
Pageof 41
Internal Medicine (Tokyo, Japan)|February 16, 2012
A case of cortisol producing adrenal adenoma associated with a latent aldosteronoma: usefulness of the ACTH loading test for the detection of covert aldosteronism in overt Cushing syndromeDaisuke Kukidome, Nobuhiro Miyamura, Kourin Sakakida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|February 1, 2022
Validation of models predicting lymph node involvement probability in patients with prostate cancerLeandro Blas, Masaki Shiota, Shohei Nagakawa, et al.
International Cancer Conference Journal|June 1, 2019
Progression to bone-marrow carcinomatosis and extraosseous legion during treatment with radium-223 for multiple bone metastasesTakahiko Hajime, Masaki Shiota, Tatsuro Abe, et al.
World Journal of Urology|December 17, 2022
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomyLeandro Blas, Masaki Shiota, Dai Takamatsu, et al.
Cancer Science|May 20, 2021
Long-term outcomes of androgen deprivation therapy in prostate cancer among Japanese men over 80 years oldLeandro Blas, Mizuki Onozawa, Masaki Shiota, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Cyclophosphamide-using nonmyeloablative allogeneic cell therapy against renal cancer with a reduced risk of graft-versus-host diseaseMasatoshi Eto, Masahiko Harano, Katsunori Tatsugami, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 18, 2022
Testosterone level in seminal vesicle fluid is a better indicator of erectile function than serum testosterone in patients with prostate cancerEiji Kashiwagi, Masaki Shiota, Hidekazu Naganuma, et al.
Oncology Reports|April 8, 2015
Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cellsTakanobu Motoshima, Yoshihiro Komohara, Hasita Horlad, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 21, 2023
NR5A2/HSD3B1 pathway promotes cellular resistance to second-generation antiandrogen darolutamideMasaki Shiota, Miho Ushijima, Shigehiro Tsukahara, et al.
Urologic Oncology|October 20, 2020
Prognostic significance of complete blood count parameters in castration-resistant prostate cancer patients treated with androgen receptor pathway inhibitorsAsako Machidori, Masaki Shiota, Satoshi Kobayashi, et al.
Pageof 41